0,942  0,004  Antineoplastic (breast cancer)
0,941  0,003  Antileukemic
0,929  0,005  Apoptosis agonist
0,925  0,005  Antiinflammatory
0,909  0,004  Antineoplastic (colorectal cancer)
0,908  0,004  Antineoplastic (colon cancer)
0,907  0,004  Antineoplastic (lung cancer)
0,899  0,003  Nitric oxide antagonist
0,888  0,007  Transcription factor NF kappa B inhibitor
0,871  0,004  Antineoplastic (ovarian cancer)
0,867  0,004  Antineoplastic (melanoma)
0,852  0,004  Antineoplastic (glioma)
0,840  0,003  Antineoplastic (glioblastoma multiforme)
0,837  0,004  Antineoplastic (pancreatic cancer)
0,833  0,003  Antineoplastic (liver cancer)
0,827  0,002  Antialcoholic
0,803  0,003  Antineoplastic (multiple myeloma)
0,803  0,005  Prostate cancer treatment
0,782  0,005  Antineoplastic (non-small cell lung cancer)
0,766  0,004  Antineoplastic (brain cancer)
0,722  0,005  Antimitotic
0,720  0,009  Chemopreventive
0,713  0,005  Antineoplastic (carcinoma)
0,696  0,005  Immunosuppressant
0,672  0,005  Antineoplastic (renal cancer)
0,674  0,008  Antineoplastic (cervical cancer)
0,668  0,005  Antineoplastic enhancer
0,642  0,005  Antineoplastic (lymphocytic leukemia)
0,624  0,010  Antineoplastic (myeloid leukemia)
0,617  0,016  Antiprotozoal
0,604  0,010  Antiparasitic
0,591  0,005  Antineoplastic (squamous cell carcinoma)
0,617  0,034  Caspase 9 stimulant
0,585  0,005  Antineoplastic (gastric cancer)
0,598  0,019  Antibacterial
0,585  0,008  Tumour necrosis factor alpha release inhibitor
0,586  0,011  Antipsoriatic
0,573  0,007  Antihelmintic
0,577  0,012  AR expression inhibitor
0,556  0,013  Antifungal
0,557  0,017  Cytotoxic
0,543  0,012  Antiprotozoal (Leishmania)
0,544  0,019  Sensitization
0,552  0,033  CYP3A4 substrate
0,532  0,019  Immunomodulator
0,521  0,019  Hepatic disorders treatment
0,506  0,007  Hepatoprotectant
0,513  0,025  Bone diseases treatment
0,488  0,004  Antifungal enhancer
0,482  0,013  Antineoplastic (endocrine cancer)
0,471  0,007  Abortion inducer
0,485  0,022  Cytostatic
0,462  0,003  Farnesoid X receptor antagonist
0,467  0,011  Antiulcerative
0,475  0,032  Respiratory analeptic
0,451  0,009  Contraceptive
0,484  0,051  TNF expression inhibitor
0,431  0,014  Transcription factor STAT inhibitor
0,460  0,046  Antipruritic, allergic
0,435  0,021  Antineoplastic (lymphoma)
0,439  0,026  Mutagenic
0,417  0,007  Protein kinase stimulant
0,428  0,031  Antiosteoporotic
0,418  0,026  Proliferative diseases treatment
0,411  0,021  Calcium channel activator
0,420  0,030  Carcinogenic
0,419  0,029  NOS2 expression inhibitor
0,393  0,008  Interleukin 6 antagonist
0,417  0,032  Antioxidant
0,405  0,038  ICAM1 expression inhibitor
0,378  0,013  Antiacne
0,376  0,019  Growth hormone agonist
0,402  0,051  Antiprotozoal (Plasmodium)
0,353  0,004  Growth stimulant
0,376  0,044  Analeptic
0,420  0,094  Antineoplastic (solid tumors)
0,355  0,031  Transcription factor STAT3 inhibitor
0,318  0,004  Inducible nitric-oxide synthase inhibitor
0,345  0,037  Antineoplastic (small cell lung cancer)
0,323  0,018  Antipruritic, non-allergic
0,323  0,024  Non-steroidal antiinflammatory agent
0,326  0,031  Antineoplastic (sarcoma)
0,331  0,046  Antiprotozoal (Trypanosoma)
0,344  0,059  Apoptosis antagonist
0,300  0,020  Interferon gamma antagonist
0,288  0,010  Antineoplastic antibiotic
0,280  0,003  Microtubule formation inhibitor
0,304  0,029  Antiviral (Influenza)
0,289  0,020  Sepsis treatment
0,306  0,047  Angiogenesis stimulant
0,284  0,030  UGT2B7 substrate
0,275  0,022  Prostate disorders treatment
0,260  0,008  Contraceptive female
0,282  0,032  VCAM1 expression inhibitor
0,267  0,021  Antiviral (Influenza A)
0,243  0,001  Antitreponemal
0,313  0,080  Antithrombotic
0,301  0,070  Spasmolytic
0,296  0,073  Cardioprotectant
0,258  0,034  Neurotrophic factor enhancer
0,293  0,076  Antineoplastic (osteosarcoma)
0,227  0,013  Arachidonic acid antagonist
0,249  0,041  Pneumotoxic
0,228  0,022  Protein-tyrosine phosphatase 1B inhibitor
0,211  0,009  Adenylate cyclase stimulant
0,293  0,095  Cholesterol antagonist
0,205  0,009  Nitric-oxide synthase inhibitor
0,268  0,071  Teratogen
0,292  0,097  Angiogenesis inhibitor
0,192  0,004  Hypercalcemia treatment
0,188  0,001  Tubulin agonist
0,216  0,030  Antineoplastic (bone cancer)
0,193  0,013  Antibiotic
0,250  0,073  Cardiovascular analeptic
0,187  0,010  Transcription factor NF kappa B stimulant
0,183  0,008  T cell inhibitor
0,186  0,015  Androgen antagonist
0,180  0,010  Aromatase inhibitor
0,205  0,045  Protein-tyrosine phosphatase inhibitor
0,272  0,113  Vasodilator, coronary
0,234  0,078  Embryotoxic
0,176  0,020  Antineoplastic alkaloid
0,255  0,100  NOS3 expression inhibitor
0,208  0,054  Antiviral (Hepatitis)
0,197  0,046  Hair growth stimulant
0,209  0,058  P-glycoprotein inhibitor
0,146  0,002  Microtubule stabilization
0,171  0,028  Beta amyloid protein antagonist
0,227  0,089  Antipyretic
0,179  0,043  Antiprotozoal (Coccidial)
0,151  0,017  Anabolic
0,247  0,115  Caspase 3 stimulant
0,138  0,009  Na+ K+ transporting ATPase inhibitor
0,201  0,071  Platelet adhesion inhibitor
0,181  0,056  ATPase inhibitor
0,218  0,096  DNA synthesis inhibitor
0,152  0,032  Alcohol dehydrogenase substrate
0,192  0,077  UGT1A1 substrate
0,225  0,111  UGT2B4 substrate
0,235  0,122  GST M1-1 substrate
0,154  0,044  Antiviral (Hepatitis B)
0,150  0,043  Ca2+-transporting ATPase inhibitor
0,169  0,063  Uterine stimulant
0,109  0,005  Heme oxygenase stimulant
0,165  0,062  UGT2B9 substrate
0,112  0,010  Protein 50S ribosomal subunit inhibitor
0,171  0,075  Muscle relaxant
0,163  0,069  Antiviral (Herpes)
0,122  0,029  Paget's disease treatment
0,166  0,074  Prostatic (benign) hyperplasia treatment
0,103  0,011  Antimycoplasmal
0,160  0,069  Melanin inhibitor
0,132  0,042  Aldehyde dehydrogenase substrate
0,169  0,081  Lipocortins synthesis antagonist
0,090  0,004  Parathyroid hormone antagonist
0,093  0,007  Lipocortins synthesis agonist
0,091  0,008  Postcoital contraceptive
0,103  0,022  Narcotic antagonist
0,106  0,026  Nicotinic alpha4beta2 receptor antagonist
0,187  0,115  Vasodilator
0,102  0,034  Contraceptive male
0,201  0,133  Chemoprotective
0,106  0,041  Actinic keratosis treatment
0,155  0,090  UGT2B10 substrate
0,067  0,004  Vanilloid 3 antagonist
0,075  0,013  5-Alpha-reductase inhibitor
0,215  0,154  CYP3A4 inhibitor
0,064  0,004  Vitamin D receptor antagonist
0,082  0,022  Postmenopausal disorders treatment
0,184  0,124  Vascular (periferal) disease treatment
0,186  0,127  Antihypotensive
0,156  0,097  Diabetic nephropathy treatment
0,160  0,102  Septic shock treatment
0,122  0,064  Proteasome inhibitor
0,107  0,049  UGT2B11 substrate
0,091  0,033  Lipase inhibitor
0,201  0,144  Antihypoxic
0,092  0,038  Thioredoxin reductase inhibitor
0,071  0,017  Acetyl-CoA transferase 2 inhibitor
0,119  0,069  Alkylator
0,077  0,028  Glutamate (mGluR6) antagonist
0,168  0,120  Hypolipemic
0,091  0,045  Acetylcholine nicotinic antagonist
0,183  0,137  Lipoprotein disorders treatment
0,060  0,018  Adenylate cyclase 1 inhibitor
0,178  0,136  DNA damaging
0,146  0,109  Sedative
0,050  0,014  p53 inhibitor
0,040  0,004  Progesterone receptor B antagonist
0,131  0,098  Eye irritation, high
0,057  0,026  Anesthetic inhalation
0,035  0,006  Progesterone agonist
0,098  0,070  Expectorant
0,174  0,147  5 Hydroxytryptamine release stimulant
0,091  0,064  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,145  0,119  LDLR expression enhancer
0,053  0,028  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,030  0,007  Corticosteroid-like
0,104  0,082  Cholesterol synthesis inhibitor
0,051  0,029  Potassium channel Kv1.3 blocker
0,095  0,073  Nav1.1 sodium channel blocker
0,068  0,047  Neuronal nicotinic receptor antagonist
0,191  0,171  5 Hydroxytryptamine uptake stimulant
0,027  0,012  CYP24 inhibitor
0,097  0,083  GST T1-1 substrate
0,057  0,046  Androgen agonist
0,033  0,022  Glucocorticoid antagonist
0,146  0,136  Antirickettsial
0,019  0,009  Telomerase stimulant
0,103  0,094  Shock treatment
0,088  0,080  Glutathione S-transferase substrate
0,031  0,024  ATP citrate lysase inhibitor
0,095  0,088  Interleukin 1b antagonist
0,099  0,095  Menstruation disorders treatment
0,095  0,091  DNA polymerase I inhibitor
0,004  0,003  Vitamin D-like
0,015  0,014  Vitamin D receptor agonist
0,064  0,063  SULT2A1 substrate
0,048  0,048  Nicotinic receptor alpha7 subunit antagonist

